Media ReleasesNext Science

View All Next Science News


Next Science - AGM Chair & Managing Director Addresses


Chair Address

Ladies and gentlemen,

My name is Mark Compton and I am delighted to join with fellow shareholders today in my first AGM as Chair of our company.

Let me begin by reaffirming our vision and purpose. At Next Science, we are driven by a clear vision to heal patients and save lives by providing solutions to prevent, treat and eliminate biofilm-based bacteria.

Next Science has a unique opportunity. We can, and are, making a real difference to the lives of people across the globe with our unique XBIOTM platform technology and suite of patented products. Our people (including the Board) are committed to this purpose, and we are dedicated in pursuing our purpose of making our products available worldwide. 

For more information, download the attached PDF.

Download this document

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.